Careers  |  Sign In  |  Register

Dr. Kudchadkar on the Biological Differences Between Ocular and Cutaneous Melanoma

Ragini R. Kudchadkar, MD, associate professor Department of Hematology and Medical Oncology, associate director of Hematology and Medical Oncology Fellowship Program – Clinical/Service at Emory University School of Medicine in the Winship Cancer Institute, discusses treating metastatic ocular melanoma, which primarily metastatizes to the liver and is less responsive to traditional therapies. Dr. Kudchadkar explains the primary treatment for metastatic ocular melanoma is administered through clincal trials, referencing phase 3 clinical trials for GP100, a human melanoma peptide vaccine, and Delcath hepatic perfusion.

Learn more by clicking here.